Ghent University Academic Bibliography

Advanced

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.

Veronique Cocquyt UGent, S VAN BELIE, RR REINHARDT, MLA DECRAMER, M O'BRIEN, JHM SCHELLENS, M BORMS, L VERBEKE, F VAN AELST and M DE SMET, et al. (2001) EUROPEAN JOURNAL OF CANCER. 37(7). p.835-842
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
EUROPEAN JOURNAL OF CANCER
Eur. J. Cancer
volume
37
issue
7
pages
835-842 pages
Web of Science type
Article
Web of Science id
000168714800010
JCR category
ONCOLOGY
JCR impact factor
3.46 (2001)
JCR rank
21/107 (2001)
JCR quartile
1 (2001)
ISSN
0959-8049
language
English
UGent publication?
yes
classification
A1
id
168754
handle
http://hdl.handle.net/1854/LU-168754
date created
2004-01-14 13:40:00
date last changed
2008-06-17 20:36:59
@article{168754,
  author       = {Cocquyt, Veronique and VAN BELIE, S and REINHARDT, RR and DECRAMER, MLA and O'BRIEN, M and SCHELLENS, JHM and BORMS, M and VERBEKE, L and VAN AELST, F and DE SMET, M and CARIDES, AD and ELDRIDGE, K and GERTZ, BJ},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  language     = {eng},
  number       = {7},
  pages        = {835--842},
  title        = {Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.},
  volume       = {37},
  year         = {2001},
}

Chicago
Cocquyt, Veronique, S VAN BELIE, RR REINHARDT, MLA DECRAMER, M O’BRIEN, JHM SCHELLENS, M BORMS, et al. 2001. “Comparison of L-758,298, a Prodrug for the Selective Neurokinin-1 Antagonist, L-754,030, with Ondansetron for the Prevention of Cisplatin-induced Emesis.” European Journal of Cancer 37 (7): 835–842.
APA
Cocquyt, V., VAN BELIE, S., REINHARDT, R., DECRAMER, M., O’BRIEN, M., SCHELLENS, J., BORMS, M., et al. (2001). Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. EUROPEAN JOURNAL OF CANCER, 37(7), 835–842.
Vancouver
1.
Cocquyt V, VAN BELIE S, REINHARDT R, DECRAMER M, O’BRIEN M, SCHELLENS J, et al. Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. EUROPEAN JOURNAL OF CANCER. 2001;37(7):835–42.
MLA
Cocquyt, Veronique, S VAN BELIE, RR REINHARDT, et al. “Comparison of L-758,298, a Prodrug for the Selective Neurokinin-1 Antagonist, L-754,030, with Ondansetron for the Prevention of Cisplatin-induced Emesis.” EUROPEAN JOURNAL OF CANCER 37.7 (2001): 835–842. Print.